Corcept Therapeutics Incorporated (CORT)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 679,589 | 506,705 | 501,842 | 375,806 | 523,338 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $679,589K)
= 0.00
The debt-to-capital ratio for Corcept Therapeutics Incorporated has consistently remained at 0.00 from December 31, 2020, to December 31, 2024. A debt-to-capital ratio of 0.00 indicates that the company has no debt in its capital structure during this period. This implies that the company is financing its operations and growth primarily through equity rather than debt. A low or zero debt-to-capital ratio can signify a lower financial risk for the company as it is not relying heavily on borrowed funds. In this case, Corcept Therapeutics Incorporated seems to have a strong and stable financial position with minimal debt obligations relative to its capital.
Peer comparison
Dec 31, 2024